Table 2.
Identification of the common genes among all tissues represented in Venn diagrams from Fig. 2.
| M | P1-AI | SP-P1 | SP-Ejac | ||||
|---|---|---|---|---|---|---|---|
| UP (19) | DOWN (48) | UP (2) | DOWN (1) | UP (1) | DOWN (0) | UP (0) | DOWN (0) |
| ABCA9, FAM107A, FIGF, FMO1, FMO2, GAB1, CCDC68, MICAL3,NDRG4, SLC2A12, LOC106504056, EZH1, PPIP5K1, DECR2, ALDH6A1, CHDH, LOC100522894, GLUL, NCOA2 | LOC100523107, FAM98A, CALR, VIMP, MIR671, EMC3, CALU, CPQ, SNX31, TMEM263, SEC. 23A, TPM4, RAI14, ARF4, TCEAL8, OSTC, B4GALT1, LOC100514264, RCN1, DNAJB11, ABHD2, GPX8, TSPAN6, HSPA13, FKBP4, KDELR3, TRPC5, LPPR5, FRD1, FAM69A, LOC100624484, SNAI2, REXO2, TDG, OLFML3, FAM19A4, HTR2A, CLRN3, DLGAP2, SRPX2, OLFM3, ENPEP, TAC3, PLAUR, VCAN, FGFBP1, HTRA4 |
AOAH LOC102162715 |
KIT | NMNAT1 | |||
Mating (M) or artificial deposition of the sperm-peak portion P1 (P1-AI); sperm-free seminal plasma of from P1-fraction P1 (SP-P1) or of the whole ejaculate (SP-Ejac). All treatments were compared to Control (AI with 50 mL of BTS).